Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 059280/0107 | |
| Pages: | 4 |
| | Recorded: | 03/16/2022 | | |
| Attorney Dkt #: | 21721-0401_ONE |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
06/14/2022
|
Application #:
|
16312647
|
Filing Dt:
|
12/21/2018
|
|
Publication #:
|
|
Pub Dt:
|
10/31/2019
| | | | |
|
Title:
|
Prevention or Treatment of Hematologic Malignancy Relapse Using a TNFR2 Antagonist
|
|
|
Assignees
|
|
|
|
|
| 61 AVENUE DU GÉNÉRAL DE GAULLE |
| CRETEIL, FRANCE 94000 |
|
|
|
|
|
| 101 RUE DE TOLBIAC |
| PARIS, FRANCE 75013 |
|
|
|
|
|
| 3 AVENUE VICTORIA |
| PARIS, FRANCE 75004 |
|
|
|
|
|
| 21 RUE D'ECOLE DE MÉDECINE |
| PARIS, FRANCE 75006 |
|
|
|
|
|
| 3 RUE MICHEL-ANGE |
| PARIS, FRANCE 75016 |
|
|
Correspondence name and address
|
| |
LIN J. HYMEL
|
| |
VERRILL DANA LLP
|
| |
ONE FEDERAL STREET, 20TH FLOOR
|
| |
BOSTON, MA 02110
|
Search Results as of:
05/26/2024 10:40 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
